Model Economic Township (MET City), a wholly owned subsidiary of Reliance Industries Limited (RIL) is developing a world-class greenfield smart city near Gurugram, Haryana. MET City is a Japan Industrial Township (JIT) and houses four leading Japanese companies in its integrated industrial township. Nihon Kohden, a manufacturer of medical devices, recently did a ground-breaking ceremony on their plot at MET City. This facility will be the company’s largest manufacturing facility in India, and it will further enhance the position of MET City as a leading location for setting up companies in Haryana and North India. Panasonic, Denso and T-Suzuki are the other Japanese companies in MET City. On the occasion of the ceremony, SV Goyal, CEO & Whole-Time Director, MET City, has said, “We are very happy to have the facility of Nihon Kohden starting construction at MET City. With 400+ industrial customers, a walk-to-work masterplan and world-class infrastructure, MET City is one of the fastest growing greenfield smart cities in North India.” He added that the plug-and-play infrastructure of MET City is an added advantage for any company for their requirement. Vaibhav Mittal, Vice President & Head Business Development, MET City, has said, “We feel immensely proud in having this world-class facility from Nihon Kohden being set up at MET City. As we grow, we continue to strive to get more Japanese companies to MET City and make it one of the most sought-after business cities of North India.” “We are very pleased to announce the opening of our new haematology analyser reagent factory,” said Kentaro Kusano, Managing Director, Nihon Kohden India, “This 8,900 sq m factory will be built on 16,135 sq m of land at MET City in Jhajjar district of Haryana, which will be almost four times bigger than our current factory in Gujarat. This facility marks an important milestone for our commitment to growing our business in India and positions Nihon Kohden well to achieve our vision for India – to be a trusted partner and provider to improve healthcare in the country.” “With the opening of this new manufacturing unit, our focus continues to be providing the latest Japanese technologies and quality products in the Indian market. This facility will allow us to further expand our manufacturing capabilities and meet the growing local needs for haematology reagents,” commented Anil Srivastava, Chief Operating Officer, Nihon Kohden India. “This step is building on Nihon Kohden’s long-term commitment to the Indian market. We would like to express thanks to our customers for their encouragement and overwhelming support to our journey so far. India is one of the most important markets for Nihon Kohden Corporation, Japan.” Summing up the significance of this move, Sameer Sehgal, Chief Finance Officer, Nihon Kohden India, said, There is a growing demand in the in-vitro diagnostic industry created by the expansion of the healthcare market in India. By adding another manufacturing plant, we expect to increase our production capacity multi-folds and drive ongoing commitment to support our existing and new customers and serve them better.